The Premier Biotech COVID-19 IgG/IgM Antibody Rapid Test is an immunoassay for identifying anti-SARS-COV-2 IgG and IgM in whole venous blood, serum, plasma, and fingerstick whole blood. The result offers an indication of possible infection of SARS-COV-2, otherwise known as COVID-19.
Easy Testing and Analysis The Premiere Biotech rapid test can be quickly conducted on location and at the point of care. It has uncomplicated instructions and a chromatographic format that indicates the presence of SARS-COV-2 antibodies and test sample validity through the emergence of red lines.
Each cassette is clearly labeled for the sample and buffer wells. The IgG, IgM, and control result windows are also easy to read and differentiate. The test can be stored at room temperature and comes with a quick interpretation guide to allow medical professionals to easily access and use the tests.
Rapid Testing Process The product features quick testing and processing times ideal for mass non-diagnostic screening. The test procedure is broken down into a few simple steps. Once complete, the results are readable in as little as 10 minutes. Uninterpreted cassettes over 20 minutes are invalid for reading.
Self-contained Kit Each kit has all the necessary materials to test up to 20 individual samples. Included are test cassettes, disposable lancets, alcohol swabs, capillaries, buffers, and information texts.
Emergency Use Authorized The Premier Biotech rapid test is CLIA-waived and has FDA emergency use authorization as a means of qualitatively identifying and differentiating adaptive immune responses to a possible recent or previous COVID-19 infection. The kit is only cleared for use in authorized laboratories and settings.
The Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette provides quick, on-site COVID-19 screening available to frontline healthcare providers.